Explore Our Latest News
May 13, 2025
News
Nomic Bio Debuts $50 Proteome with Absolute Quantification Through Launch of Omni 1000
For the first time, researchers can access a quantitative proteome-wide solution that profiles 1000 of the most informative proteins at high-throughput.
Recent Articles
News
May 13, 2025
Omni 1000 Grant Opportunity in High Plex Proteomics
News
May 13, 2025
Nomic Bio Debuts $50 Proteome with Absolute Quantification Through Launch of Omni 1000
For the first time, researchers can access a quantitative proteome-wide solution that profiles 1000 of the most informative proteins at high-throughput.
News
January 3, 2025
Bridging the Gaps in Proteomics
Enabling well-powered studies, absolute quantification, and unlimited content flexibility
News
September 24, 2024
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) Launch Large-Scale Protein Profiling to Investigate Immunotherapy Responses in RADIOHEAD Study
Project will quantify circulating protein markers in ~3000 patient blood samples from PICI’s RADIOHEAD study using Nomic’s nELISA™ high-throughput protein profiling platform to better understand how patients respond to treatment
News
September 17, 2024
Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling
The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.
News
June 28, 2023
Nomic Bio Appoints Byron Hewett to its Board of Directors
Hewett brings invaluable operational and strategic expertise to guide Nomic Bio through its crucial years of growth.
News
December 8, 2021
Nomic Closes $17 Million Series A to Develop and Commercialize the World’s Highest Throughput Proteomic Platform
Nomic is closing of an oversubscribed US$17 million Series A funding round, bringing the company's total funding to date to over US$21 million.
News
December 8, 2021
Nomic to Provide nELISA to JUMP Cell Painting Consortium to Measure Protein Secretome for Phenotypic Drug Discovery
Nomic’s nELISA will be used to profile 200 secreted proteins for ten thousand samples to provide consortium partners complementary information about the secretome